Vitrolife AB (publ)

PNK: VTRLY · Real-Time Price · USD
18.00
0.00 (0.00%)
At close: Apr 29, 2025, 9:35 AM

Company Description

Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction.

It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products.

The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors.

It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America.

The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998.

Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.

Vitrolife AB (publ)
Vitrolife AB (publ) logo
Country SE
IPO Date Aug 10, 2016
Industry Medical - Devices
Sector Healthcare
Employees 1,150
CEO Bronwyn Brophy O´Connor

Contact Details

Address:
Gustaf Werners gata 2
Gothenburg,
SE
Website https://www.vitrolife.com

Stock Details

Ticker Symbol VTRLY
Exchange PNK
Fiscal Year January - December
Reporting Currency USD
CIK Code n/a
CUSIP Number n/a
ISIN Number US92852Y1010
Employer ID -
SIC Code n/a

Key Executives

Name Position
Bronwyn Brophy O´Connor Chief Executive Officer & President
Ermanno Sironi Chief Operating Officer
Helena Wennerström Acting Chief Financial Officer
Claus Bisgaard Senior Vice President of Technologies
Dr. Meishan Jin Senior Vice President & GM of China
Jessica Jonasson Chief HR Officer
Marcos Jose Fernandez Vice President Strategy, Sustainability & Corporate Development
Olivia Natens Senior Vice President of Sales & Marketing
Ricardo Capella Senior Vice President Genetic Services
Rickard Ericsson Senior Vice President Innovation

Latest SEC Filings

No SEC filings available.